News News Articles Articles Conference Conference Store Store Links Links Classifieds Classifieds Newsletters Newsletters Home | Sponsors | Resources | Contact Us



MEMBERS NON-MEMBER DOCTORS PATIENTS INTERNATIONAL CHAPTERS







IAOMT News


IAOMT News

Congress To Hear FDA's Failure To Classify Amalgam Back
11/02/2007


Congress Demands Account from FDA for Refusing

To Classify Mercury Fillings & Refusing To Do E.I.S.

Members of Congress increasingly disgusted with FDA’s refusal to classify mercury fillings and refusing to do an Environmental Impact Statement about this issue are calling the agency to task. At the request of Congresswoman Diane Watson and Congressman Dan Burton, the Subcommittee on Domestic Policy of the House Committee on Government Reform will have a hearing in the Rayburn Bldg. on Wed., Nov. 14, 2007, at 2:00 pm. The Chairman of the Subcommittee is maverick Congressman Dennis Kucinich of Ohio, a friend of alternative medicine. We express our deep appreciation to Congressman Kucinich for calling FDA to account.

--Charlie Brown, National Counsel, Consumers for Dental Choice

Background: Since 1976, the FDA has placed all medical devices into three classifications based on the relative risk each poses to human safety, but they have always managed to avoid classifying pre-capsulated and mixed dental amalgam. Class I devices pose the least risk, and require the least oversight. Examples are band-aids, exam gloves, and dental mercury! Class II devices present moderate risk and get more regulatory oversight. Examples are powered wheelchairs, infusion pumps, and dental alloy. Class III devices pose serious risks, and require proof of safety and efficacy. Examples of these include breast implants and replacement heart valves.

The fact that there is no classification for pre-capsulated and mixed dental amalgam means that the amalgam-using dentist is the manufacturer of record of an unregulated product. The liability issues have never been tested. In recent years, the pro-amalgam FDA staff has made some moves to quietly place all amalgam in Class II, which would remove it from serious examination of safety issues, but they have been opposed by IAOMT and Consumers for Dental Choice. Our respective lobbying efforts have led to the hearing scheduled for November 14, to once again bring the FDA's failure to deal honestly with amalgam into the light.


I went serching for a doctor close to me and got this.Hopefully Congress will use q-tips prior to the meeting








Copyright 2006. IAOMT. All Rights Reserved.
Website by GUI Visions About Us | Mission | Disclaimer | Privacy | Sitemap
Admin

Yes Q-tips for sure, let us hope this one does not fall on deaf ears!!!

Thanks for sharing Melissa.

Sandi
xoxo